<DOC>
	<DOCNO>NCT02823080</DOCNO>
	<brief_summary>To evaluate safety efficacy 3-day cetrotide therapy start day oocyte retrieval ( Day-0 ) woman high-risk development ovarian hyperstimulation syndrome ( OHSS ) gonadotropin- release hormon agonist induction protocol . Patients &amp; Methods : Forty-eight woman fulfil inclusion criterion underwent ultrasound scan maximal ovarian diameter ( MOD ) estimation ascites grade . Patients underwent embryo freezing , study group receive 3-day Cetrotide sc injection ( 0.25 mg/day ) start Day-0 . Serum E2 , pain score MOD check daily . Hematocrit value ( Ht % ) , total leucocytic count ( TLC ) , gastrointestinal ( GI ) manifestation ascites grade re-evaluated Day-3 , 6 8</brief_summary>
	<brief_title>Outcome Cetrotide Therapy Management Women High-risk Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description>The current study conduct Assisted Reproduction Unit Almana general Hospital , kingdom saudi arabia.and private center Egypt . The study protocol approve Local Ethical Committee . The study aim include woman suspect high risk development OHSS agonist ovarian stimulation protocol.The study include woman couple sing write consent participate study , undergo embryo freeze postpone transfer cryopreserved embryo . All patient clinically evaluate presence abdominal pain present graduate use numerical pain visual analogue scale ( VAS ) 0 mean pain 10 mean severe intolerable pain . Patients evaluate presence nausea and/or vomit sense abdominal distension . Symptoms score use verbal analogue scale nil , mild , moderate , severe symptom . Blood sample obtain complete aseptic condition estimation serum E2 level determination hematocrit value ( Ht % ) total leucocytic count ( TLC ) . Then , patient underwent ultrasound scan estimation ovarian measurement represent maximal ovarian diameter ( MOD ) ascites grade present . Ultrasound scan perform use 5 megahertz vaginal probe , otherwise 3.5 megahertz , 2.6 megahertz 5megahertz abdominal probe use visualization use vaginal probe compromise . Ascites grade accord quantity fluid accumulation peritoneal cavity patient anti-Trendelenburg position . Women fulfil inclusion criterion randomely allocate , use seal envelops , two equal group . Group embryo freeze alone ( Control group ) group additionally receive cetrotide subcutaneous injection daily dose 0.25 mg start day oocyte retrieval 3 day ( Study group ) . Symptomatic treatment associate symptom analgesic , antiemetic antispasmodic also prescribe . Patients categorize accord classification grading OHSS . Class Clinical feature Biochemical feature Mild - Abdominal distension/ discomfort - Mild nausea/vomiting - Diarrhea - Ovarian size usually &lt; 8 cm No clinically important laboratory finding Moderate - Mild feature plus - US evidence ascites - Elevated Ht ( &gt; 41 % ) - Elevated TLC &gt; 15,000/ ml - Hypoproteinemia Severe - Mild &amp; Moderate feature plus - Clinically detect ascites - Severe abdominal pain - Intractable nausea - Rapid weight gain ( &gt; 1 kg/24 hr ) - Pleural effusion - Severe dyspnea - Oliguria/anuria - Low blood/central venous pressure - Syncope - Venous thrombosis - Hemoconcentration ( Ht &gt; 55 % ) - TLC &gt; 25,000/ ml - Serum creatinine &gt; 1.6 mg/dl - creatinine clearance &lt; 50 ml/min - Hyponatremia ( Na+ &lt; 135milliequivalent per litre ) - Hypokalemia ( K+ &lt; 5 milliequivalent per litre ) - Elevated liver enzymes Critical - Severe feature plus - Anuria/ Acute renal failure - Arrhythmia - Pericardial effusion - Massive hydrothorax - Thrombo-embolism - Arterial thrombosis - ( ARDS ) Adult respiratory distress syndrome - Sepsis - Worsening biochemical finding see severe OHSS US : Ultrasound ; Ht % : Ht ; Hematocrit value ; TLC : Total leucocytic count : ARDS ; adult respiratory distress syndrome . All patient manage outpatient unless management severe symptom necessitate hospital admission . Pain score , serum E2 level MOD evaluate daily . Patients evaluate associated symptom previously determine clinical evaluation , ascites grade TLC Ht value evaluate 3 6 day end trial 8th day oocyte retrieval .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>1. number retrieve oocytes ≥20 2. mean number follicle diameter &gt; 16 mm ≥18 3. serum E2 concentration ≥3500 pg/ml 4. ovarian diameter day ovum retrieval &gt; 10 cm 5. presentation evident symptom OHSS day aspiration . 1 Absence one item inclusion criterion .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>